Effector Mechanisms Operative in Adoptive Therapy of Tumor-Bearing Animals: Implications for the Use of Interleukin-2
Interleukin-2 Administered In Vivo Induces the Growth and Augments the Function of Cultured T Cells In Vivo
Expansion of Murine Cytotoxic Precursors In Vitro and In Vivo by Purified Interleukin-2
Systemic Administration of Interleukin-2 in Humans
Treatment of Immunodeficiency with Interleukin-2: Initial Exploration
Intralesional Injection of Interleukin-2—Expanded Autologous Lymphocytes in Melanoma and Breast Cancer Patients: A Pilot Study
Immunotherapy of Cancer by Systemic Administration of Lymphoid Cells Plus Interleukin-2
Use of Interleukin-2 in Patients with Acquired Immunodeficiency Syndrome
Immunotherapy of Murine and Human Tumors in Mice with Lymphokines and Interleukin-2-Propagated Lymphocytes
Summary: Potential of Interleukin-2 for the Therapy of Cancer
Abnormal Indomethacin-Sensitive Suppression in Peripheral Blood Mononuclear Cells of Cancer Patients Restricts Augmentation by Interleukin-2
Evaluation of Effect of Levamisole on Feline Mammary Cancer
Suppression by Tumor Growth of T Cell Growth Factor Production in Mouse Lymphoid Cell Cultures
Systemic Administration of Recombinant Human Interleukin-2 in Mice